Calcipotriol

DRUG16 trials

Sponsors

GlaxoSmithKline, Rabin Medical Center, LEO Pharma, NeoStrata Company, Inc., Zalicus

Conditions

Actinic KeratosesActinic Keratosis of Face and ScalpAlopecia AreataCentral Centrifugal Cicatricial AlopeciaChronic Plaque PsoriasisPlaque PsoriasisPlaque Type PsoriasisPsoriasis

Early Phase 1

Calcipotriol as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

WithdrawnNCT05416320

Wake Forest University Health SciencesCentral Centrifugal Cicatricial Alopecia

Start: 2023-08-31End: 2023-12-31Updated: 2023-08-31

COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

Enrolling by invitationNCT06880042

Dr ayesha wahidTacrolimus, Vitiligo - Macular Depigmentation

Start: 2025-05-01End: 2025-08-30Target: 60Updated: 2025-06-24

Phase 1

Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034

CompletedNCT00358384

GlaxoSmithKlinePsoriasis

Start: 2005-09-26End: 2006-02-24Updated: 2017-11-13

SHP-141C in Plaque Type Psoriasis

CompletedNCT01646567

TetraLogic PharmaceuticalsPlaque Type Psoriasis

Start: 2012-09-30End: 2012-11-30Updated: 2014-07-11

Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

CompletedNCT03069144

Haus BioceuticalsPsoriasis, Psoriasis Vulgaris

Start: 2012-01-06End: 2012-05-28Updated: 2017-03-03

Phase 2

The Role of Calcipotriol as Radioprotector of Skin

Rabin Medical CenterRadiodermatitis

Target: 50Updated: 2007-03-08

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis

CompletedNCT00796211

ZalicusPlaque Psoriasis

Start: 2008-11-30End: 2009-01-31Target: 20Updated: 2009-01-15

LEO 90100 in the Treatment of Psoriasis Vulgaris

CompletedNCT01536938

LEO PharmaPsoriasis Vulgaris

Start: 2012-05-31End: 2012-11-30Updated: 2025-03-07

Nicotinamide in the Treatment of Psoriasis

CompletedNCT01763424

Isfahan University of Medical SciencesPsoriasis

Start: 2011-07-31End: 2012-12-31Updated: 2013-01-08

Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

CompletedNCT03848806

Haus BioceuticalsPsoriasis

Start: 2016-02-29End: 2016-09-05Updated: 2019-02-21

Phase 3

Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds

CompletedNCT00691002

LEO PharmaPsoriasis Vulgaris

Start: 2008-05-31End: 2010-01-31Updated: 2025-03-10

Phase 4

Comparison of Topical Calcipotriol and Intralesional Steroids in Alopecia Areata

Not yet recruitingNCT07453238

Hayat Abad Medical Complex, PeshawarAlopecia Areata

Start: 2026-04-01End: 2026-10-01Target: 60Updated: 2026-03-05

Unknown Phase

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

CompletedNCT00705900

NeoStrata Company, Inc.Chronic Plaque Psoriasis

Start: 2007-01-31End: 2008-11-30Target: 60Updated: 2008-11-19

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

CompletedNCT03847441

Aswan University HospitalAlopecia Areata

Start: 2017-10-01End: 2018-12-31Updated: 2019-04-02

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

CompletedNCT05954104

EgymedicalpediaAlopecia Areata

Start: 2023-07-01End: 2023-10-15Updated: 2023-10-19

Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses

Not yet recruitingNCT06685588

St Vincent's University Hospital, IrelandActinic Keratoses, Actinic Keratosis of Face and Scalp

Start: 2025-01-31End: 2026-01-31Target: 50Updated: 2024-11-12

Related Papers

Calcipotriene Plus Betamethasone Dipropionate Foam for Mild Psoriasis: Pooled Results from Three Randomized Trials

Journal of Drugs in Dermatology2021-07-011 citations

Treating Scalp Psoriasis with Calcipotriene/Betamethasone Dipropionate Fixed-dose Combination Cutaneous Foam: Review of Phase 2 Data

PubMed2020-08-014 citations